The penetrance of hereditary hemochromatosis

Best Practice and Research: Clinical Haematology

Volumn 18, Issue 2 SPEC. ISS., 2005, Pages 203-220

  Waalen, Jill ^a   Nordestgaard, Boørge G ^b   Beutler, Ernest ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

C282Y; H63D; Hemochromatosis; HFE; Iron metabolism

Indexed keywords

ALCOHOL; FERRITIN; HFE PROTEIN; TRANSFERRIN;

ARTHRALGIA; ARTHRITIS; ARTICLE; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FATIGUE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GENETIC POLYMORPHISM; GENOTYPE; HEALTH STATUS; HEMOCHROMATOSIS; HEREDITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; IRON METABOLISM; IRON OVERLOAD; LIFE EXPECTANCY; LIVER DISEASE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN PIGMENTATION; SYMPTOMATOLOGY; WILD TYPE;

EID: 14544277888     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2004.08.023     Document Type: Review

References (69)

1. J.H. Sheldon Haemochromatosis 1935 Oxford University Press London
2. D.L. Witte W.H. Crosby C.Q. Edwards et al. Hereditary hemochromatosis Clinica Chimica Acta 245 1996 139-200
3. J.N. Feder A. Gnirke W. Thomas et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nature Genetics 13 1996 399-408
4. G. Willis J.Z. Wimperis R. Lonsdale et al. Incidence of liver disease in people with HFE mutations Gut 46 2000 401-404
5. M. Worwood HFE mutations as risk factors in disease Best Practice and Research in Clinical Haematology 15 2002 295-314
6. R.V. Andersen A. Tybjaerg-Hansen M. Appleyard et al. Hemochromatosis mutations in the general population: Iron overload progression rate Blood 103 2004 2914-2919
7. Åsberg K. Hveem O. Kruger et al. Persons with screening-detected haemochromatosis: As healthy as the general population? Scandinavian Journal of Gastroenterology 37 2002 719-724
8. A. Pietrangelo Hereditary hemochromatosis - a new look at an old disease New England Journal of Medicine 350 2004 2383-2397
9. J.K. Olynyk D.J. Cullen S. Aquilia et al. A population-based study of the clinical expression of the hemochromatosis gene New England Journal of Medicine 341 1999 718-724
10. J.K. Olynyk S.E. Hagan D.J. Cullen et al. Evolution of untreated hereditary hemochromatosis in the Busselton population: A 17-year study Mayo Clinic Proceedings 79 2004 309-313
11. E. Beutler V.J. Felitti J.A. Koziol et al. Penetrance of the 845G6A (C282Y) HFE hereditary haemochromatosis mutation in the USA Lancet 359 2002 211-218
12. Y. Deugnier A.M. Jouanolle J. Chaperon et al. Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: A study of 9396 French people British Journal of Haematology 118 2002 1170-1178
13. G. Vaiopoulos G. Papanikolaou M. Politou et al. Arthropathy in juvenile hemochromatosis Arthritis and Rheumatism 48 2003 227-230
14. Z.J. Bulaj R.S. Ajioka J.D. Phillips et al. Disease-related conditions in relatives of patients with hemochromatosis New England Journal of Medicine 343 2000 1529-1535
15. E.D. Morrison D.J. Brandhagen P.D. Phatak et al. Serum ferritin level predicts advanced hepatic fibrosis among US patients with phenotypic hemochromatosis Annals of Internal Medicine 138 2003 627-633
16. D. Guyader C. Jacquelinet R. Moirand et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis Gastroenterology 115 1998 929-936
17. H. Coppin M. Bensaid S. Fruchon et al. Longevity and carrying the C282Y mutation for haemochromatosis on the HFE gene: Case control study of 492 French centenarians British Medical Journal 327 2003 132-133
18. K. Piippo J. Louhija R. Tilvis et al. You may live to the age of more than 100 years even if you are homozygous for a haemochromatosis gene mutation European Journal of Clinical Investigation 33 2003 830-831
19. M.O. Van Aken A.J. De Craen J. Gussekloo et al. No increase in mortality and morbidity among carriers of the C282Y mutation of the hereditary haemochromatosis gene in the oldest old: The Leiden 85-plus Study European Journal of Clinical Investigation 32 2002 750-754
20. P.L. Lee T. Gelbart C. West et al. A study of genes that may modulate the expression of hereditary hemochromatosis: Transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin Blood Cells, Molecules, and Diseases 27 2001 783-802
21. A.T. Merryweather-Clarke E. Cadet A. Bomford et al. Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis Human Molecular Genetics 12 2003 2241-2247
22. S. Jacolot G. Le Gac V. Scotet et al. HAMP as a modifier gene that increase the phenotypic expression of the HFE p.C282Y homozygous genotype Blood 103 2004 2835-2840
23. G. Le Gac V. Scotet C. Ka et al. The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype Human Molecular Genetics 13 2004 1913-1918
24. M.R. Langlois M.E. Martin J.R. Boelaert et al. The haptoglobin 2-2 phenotype affects serum markers of iron status in healthy males Clinical Chemistry 46 2000 1619-1625
25. H. Van Vlierberghe M. Langlois J. Delanghe et al. Haptoglobin phenotype 2-2 overrepresentation in Cys282Tyr hemochromatotic patients Journal of Hepatology 35 2001 707-711
26. E. Beutler T. Gelbart & P. Lee Haptoglobin polymorphism and iron homeostasis Clinical Chemistry 48 2002 2232-2235
27. K. Carter D.J. Bowen C.A. McCune et al. Haptoglobin type neither influences iron accumulation in normal subjects nor predicts clinical presentation in HFE C282Y haemochromatosis: Phenotype and genotype analysis British Journal of Haematology 122 2003 326-332
28. K.J. Livesey V.L. Wimhurst K. Carter et al. The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading Journal of Medical Genetics 41 2004 6-10
29. E. Beutler L. Beutler P.L. Lee et al. The mt 16,189 polymorphism and penetrance of hemochromatosis Blood Cells, Molecules, and Diseases 2004 in press
30. J.B. Whitfield G. Zhu A.C. Heath et al. Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers Alcoholism - Clinical and Experimental Research 25 2001 1037-1045
31. V. Scotet M.C. Merour A.Y. Mercier et al. Hereditary hemochromatosis: effect of excessive alcohol consumption on disease expression in patients homozygous for the C282Y mutation American Journal of Epidemiology 158 2003 129-134
32. L.M. Fletcher & L.W. Powell Hemochromatosis and alcoholic liver disease Alcohol 30 2003 131-136
33. J. Waalen V.J. Felitti T. Gelbart et al. Penetrance of hemochromatosis Blood Cells, Molecules, and Diseases 29 2002 418-432
34. P.D. Phatak D.H. Ryan J. Cappuccio et al. Prevalence and penetrance of HFE mutations in 4865 unselected primary care patients Blood Cells, Molecules, and Diseases 29 2002 41-47
35. E. Beutler Genetic irony beyond haemochromatosis: Clinical effects of HLA-H mutations Lancet 349 1997 296-297
36. V. Chambers L. Sutherland K. Palmer et al. Haemochromatosis-associated HFE genotypes in English blood donors: Age-related frequency and biochemical expression Journal of Hepatology 39 2003 925-931
37. M.J. Burt P.M. George J.D. Upton et al. The significance of haemochromatosis gene mutations in the general population: Implications for screening Gut 43 1998 830-836
38. H.A. Jackson K. Carter C. Darke et al. HFE mutations, iron deficiency and overload in 10500 blood donors British Journal of Haematology 114 2001 474-484
39. A.T. Merryweather-Clarke M. Worwood L. Parkinson et al. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population British Journal of Haematology 101 1998 369-373
40. O.T. Njajou J.J. Houwing-Duistermaat R.H. Osborne et al. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism European Journal of Human Genetics 11 2003 225-231
41. E. Beutler V. Felitti T. Gelbart et al. Haematological effects of the C282Y HFE mutation in homozygous and heterozygous states among subjects of northern and southern European ancestry British Journal of Haematology 120 2003 887-893
42. C. Datz T. Haas H. Rinner et al. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency? Clinical Chemistry 44 1998 2429-2432
43. E. Rossi M.K. Bulsara J.K. Olynyk et al. Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population Clinical Chemistry 47 2001 202-208
44. J. Rochette J.J. Pointon C.A. Fisher et al. Multicentric origin of hemochromatosis gene (HFE) mutations American Journal of Human Genetics 64 1999 1056-1062
45. S. Moalem E.D. Weinberg & M.E. Percy Hemochromatosis and the enigma of misplaced iron: Implications for infectious disease and survival Biometals 17 2004 135-139
46. D.J. Halsall I. McFarlane J. Luan et al. Typical type 2 diabetes mellitus and HFE gene mutations: A population-based case-control study Human Molecular Genetics 12 2003 1361-1365
47. A.E. Timms R. Sathananthan L. Bradbury et al. Genetic testing for haemochromatosis in patients with chondrocalcinosis Annals of the Rheumatic Diseases 61 2002 745-747
48. J.M. Ross R.M. Kowalchuk J. Shaulinsky et al. Association of heterozygous hemochromatosis C282Y gene mutation with hand osteoarthritis Journal of Rheumatology 30 2003 121-125
49. G. Willis D.G. Scott B.A. Jennings et al. HFE mutations in an inflammatory arthritis population Rheumatology (Oxford) 41 2002 176-179
50. T.P. Tuomainen K. Kontula K. Nyyssonen et al. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation - a prospective cohort study in men in eastern Finland Circulation 100 1999 1274-1279
51. M. Roest Y.T. van der Schouw B. de Valk et al. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women Circulation 100 1999 1268-1273
52. M.L. Rasmussen A.R. Folsom D.J. Catellier et al. A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: The atherosclerosis risk in communities (ARIC) study Atherosclerosis 154 2001 739-746
53. R. Surber H.H. Sigusch H. Kuehnert et al. Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: A study in 1279 patients undergoing coronary angiography Journal of Medical Genetics 40 2003 E58
54. J. Waalen V. Felitti T. Gelbart et al. Prevalence of coronary heart disease associated with HFE mutations in adults attending a health appraisal center American Journal of Medicine 113 2002 472-479
55. I.R. Gunn F.K. Maxwell D. Gaffney et al. Haemochromatosis gene mutations and risk of coronary heart disease: A west of Scotland coronary prevention study (WOSCOPS) substudy Heart 90 2004 304-306
56. S. Campbell D.K. George S.D. Robb et al. The prevalence of haemochromatosis gene mutations in the West of Scotland and their relation to ischaemic heart disease Heart 89 2003 1023-1026
57. N.J. Shaheen L.M. Silverman T. Keku et al. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer Journal of the National Cancer Institute 95 2003 154-159
58. A. Altes E. Gimferrer G. Capella et al. Colorectal cancer and HFE gene mutations Haematologica 84 1999 479-480
59. J. Hannuksela E.R. Savolainen P. Koistinen et al. Prevalence of HFE genotypes, C282Y and H63D in patients with hematologic disorders Haematologica 87 2002 131-135
60. M.T. Dorak A.K. Burnett & M. Worwood Hemochromatosis gene in leukemia and lymphoma Leukemia and Lymphoma 43 2002 467-477
61. S. Chitturi M. Weltman G.C. Farrell et al. HFE mutations, hepatic iron, and fibrosis: Ethnic-specific association of NASH with C282Y but not with fibrotic severity Hepatology 36 2002 142-149
62. Valenti, L, Dongiovanni P, Fracazani AL et al. Increased susceptibilty to nonalcoholic fatty liver disease in heterozygotes for the mutation responsiple for hereditary hemochromatosis. Digestive and Liver Diseases 2003; 35: 172-178.
63. L. Kazemi-Shirazi C. Datz T. Maier-Dobersberger et al. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C Gastroenterology 116 1999 127-134
64. L. Bathum L. Christiansen H. Nybo et al. Association of mutations in the hemochromatosis gene with shorter life expectancy Archives of Internal Medicine 161 2001 2441-2444
65. G. Willis J.Z. Wimperis K. Smith et al. HFE mutations in the elderly Blood Cells, Molecules, and Diseases 31 2003 240-246
66. J. Waalen & E. Beutler No age-related decrease in frequency of heterozygotes for the HFE C282Y haemochromatosis mutation Journal of Hepatology 40 2004 1044
67. P.C. Adams A.E. Kertesz C.E. McLaren et al. Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors Hepatology 31 2000 1160-1164
68. C. Ellervik T. Mandrup-Poulsen B.G. Nordestgaard et al. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: A retrospective study Lancet 358 2001 1405-1409
69. K.K. Steinberg M.E. Cogswell J.C. Chang et al. Prevalence of CY282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States Journal of the American Medical Association 285 2001 2216-2222